From the Department of Biomedical Science, University of Illinois College of Medicine, Rockford, Illinois.
Departments of Microbiology-Immunology and.
Allergy Asthma Proc. 2022 Nov 1;43(6):509-518. doi: 10.2500/aap.2022.43.220075.
Human monkeypox is a zoonosis caused by the monkeypox virus, an orthopoxvirus and close relative of variola virus, the causative agent of smallpox. The disease was first reported in central Africa in 1970, where it continues to be endemic and has historically affected some of the poorest and most marginalized communities in the world. The condition has recently attracted global attention due to >14,000 cases, including five deaths, reported by the World Health Organization, and a total of 5189 confirmed monkeypox cases in the United States reported by the Centers for Disease Control and Prevention as of July 29, 2022. On July 23, 2022, the World Health Organization declared the current monkeypox outbreak a Public Health Emergency of International Concern. The purpose of the present report was to review the epidemiology of monkeypox viral infection; its clinical manifestations; and current recommendations for diagnosis, treatment, and use of vaccines for prevention of the disease, with a focus on those aspects that have particular relevance to the allergist/immunologist. Monkeypox was discovered in the early 1970s and, for years, has been well described by researchers in west and central Africa, where the disease has been present for decades. Although this outbreak thus far has mostly affected men who have sex with men, it is possible that the disease could become endemic and could begin spreading in settings where there is close physical contact, which is how the virus is transmitted. Monkeypox is a different viral infection from the coronavirus. Unlike the coronavirus, which is an extremely contagious respiratory pathogen, monkeypox is primarily transmitted through body fluids and/or prolonged skin-to-skin contact. Although the control of monkeypox will require renewed efforts and resources, we have learned much from the past and have the tools to stop this virus from becoming yet another serious illness with which Americans have to contend. The allergist/immunologist can play a significant role.
人类猴痘是由猴痘病毒引起的一种人畜共患病,猴痘病毒是正痘病毒属的一种病毒,与天花病毒密切相关。这种疾病于 1970 年首次在中非报告,在那里它仍然是地方性的,历史上曾影响到世界上一些最贫穷和最边缘化的社区。由于世界卫生组织报告了超过 14000 例病例,包括 5 例死亡,以及美国疾病控制与预防中心截至 2022 年 7 月 29 日报告的总共 5189 例确诊的猴痘病例,这种情况最近引起了全球关注。2022 年 7 月 23 日,世界卫生组织宣布当前的猴痘疫情为国际关注的突发公共卫生事件。本报告的目的是回顾猴痘病毒感染的流行病学;其临床表现;以及目前对诊断、治疗和使用疫苗预防疾病的建议,重点关注那些与过敏症/免疫学家特别相关的方面。猴痘于 20 世纪 70 年代初被发现,多年来,在该疾病存在了几十年的西非和中非地区,研究人员对其进行了很好的描述。尽管此次疫情迄今为止主要影响与男性发生性关系的男性,但该疾病有可能成为地方性疾病,并可能开始在密切身体接触的环境中传播,这是病毒传播的方式。猴痘是一种与冠状病毒不同的病毒感染。与冠状病毒不同,冠状病毒是一种极具传染性的呼吸道病原体,猴痘主要通过体液和/或长时间的皮肤接触传播。虽然控制猴痘将需要重新努力和资源,但我们从过去吸取了很多教训,并且有工具来阻止这种病毒成为另一种美国人必须应对的严重疾病。过敏症/免疫学家可以发挥重要作用。